Movement Alert｜Twist Bioscience Corp Rises 5.07% in Regular Trading, Anthropic Protein Design Collaboration Continues to Drive Momentum

Market Focus00:57

On August 22, Twist Bioscience Corp rose 5.07% in regular trading, trading at $143.245/share, with turnover of $100 million, extending the prior session's surge of over 22%.

On the news front, the company disclosed on August 20 that it was selected by Anthropic as an independent evaluator for a multi-arm AI protein design project. Twist Bioscience is responsible for rapidly producing at scale the AI-designed proteins and testing the designs for binding capability. Anthropic is leveraging Claude Opus 4.8 and Mythos Preview to conduct protein design experiments targeting 15 different targets, with Twist serving as the external validation partner.

This role further solidifies the company's position as a core supplier in the DNA synthesis and protein production segments of the AI-driven drug discovery value chain. Additionally, the company reported Q3 revenue of $118.4 million, beating estimates, and issued Q4 guidance of $123-124 million, significantly above the consensus estimate of $117.4 million, providing fundamental support for the continued rally.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

1

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1169221109?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-22 00:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1169221109","market":"us","top_or_hot":-1,"title":"Movement Alert｜Twist Bioscience Corp Rises 5.07% in Regular Trading, Anthropic Protein Design Collaboration Continues to Drive Momentum","media":"Market Focus","content":"<p><p>On August 22, Twist Bioscience Corp rose 5.07% in regular trading, trading at $143.245/share, with turnover of $100 million, extending the prior session's surge of over 22%.</p><p>On the news front, the company disclosed on August 20 that it was selected by Anthropic as an independent evaluator for a multi-arm AI protein design project. Twist Bioscience is responsible for rapidly producing at scale the AI-designed proteins and testing the designs for binding capability. Anthropic is leveraging Claude Opus 4.8 and Mythos Preview to conduct protein design experiments targeting 15 different targets, with Twist serving as the external validation partner.</p><p>This role further solidifies the company's position as a core supplier in the DNA synthesis and protein production segments of the AI-driven drug discovery value chain. Additionally, the company reported Q3 revenue of $118.4 million, beating estimates, and issued Q4 guidance of $123-124 million, significantly above the consensus estimate of $117.4 million, providing fundamental support for the continued rally.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Twist Bioscience Corp Rises 5.07% in Regular Trading, Anthropic Protein Design Collaboration Continues to Drive Momentum</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Twist Bioscience Corp Rises 5.07% in Regular Trading, Anthropic Protein Design Collaboration Continues to Drive Momentum\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-22 00:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 22, Twist Bioscience Corp rose 5.07% in regular trading, trading at $143.245/share, with turnover of $100 million, extending the prior session's surge of over 22%.</p><p>On the news front, the company disclosed on August 20 that it was selected by Anthropic as an independent evaluator for a multi-arm AI protein design project. Twist Bioscience is responsible for rapidly producing at scale the AI-designed proteins and testing the designs for binding capability. Anthropic is leveraging Claude Opus 4.8 and Mythos Preview to conduct protein design experiments targeting 15 different targets, with Twist serving as the external validation partner.</p><p>This role further solidifies the company's position as a core supplier in the DNA synthesis and protein production segments of the AI-driven drug discovery value chain. Additionally, the company reported Q3 revenue of $118.4 million, beating estimates, and issued Q4 guidance of $123-124 million, significantly above the consensus estimate of $117.4 million, providing fundamental support for the continued rally.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"","article_id":"1169221109","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169221109","pubTimestamp":1787331436,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 22, Twist Bioscience Corp rose 5.07% in regular trading, trading at $143.245/share, with turnover of $100 million, extending the prior session's surge of over 22%.On the news front, the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"走势警报|Twist Bioscience Corp 常规交易上涨 5.07%，Anthropic Protein Design 合作继续推动动力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":1},"content_text":"On August 22, Twist Bioscience Corp rose 5.07% in regular trading, trading at $143.245/share, with turnover of $100 million, extending the prior session's surge of over 22%.On the news front, the company disclosed on August 20 that it was selected by Anthropic as an independent evaluator for a multi-arm AI protein design project. Twist Bioscience is responsible for rapidly producing at scale the AI-designed proteins and testing the designs for binding capability. Anthropic is leveraging Claude Opus 4.8 and Mythos Preview to conduct protein design experiments targeting 15 different targets, with Twist serving as the external validation partner.This role further solidifies the company's position as a core supplier in the DNA synthesis and protein production segments of the AI-driven drug discovery value chain. Additionally, the company reported Q3 revenue of $118.4 million, beating estimates, and issued Q4 guidance of $123-124 million, significantly above the consensus estimate of $117.4 million, providing fundamental support for the continued rally.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1169221109","isCrawlerRequest":true}